291 related articles for article (PubMed ID: 15347316)
1. Development of packaging cell lines for generation of adeno-associated virus vectors by lentiviral gene transfer of trans-complementary components.
Nakamura S; Nakamura R; Shibata K; Kobayashi M; Sahara N; Shigeno K; Shinjo K; Naito K; Ohnishi K; Kasahara N; Iwaki Y
Eur J Haematol; 2004 Oct; 73(4):285-94. PubMed ID: 15347316
[TBL] [Abstract][Full Text] [Related]
2. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
[TBL] [Abstract][Full Text] [Related]
3. Efficient expression of the vascular endothelial growth factor gene in vitro and in vivo, using an adeno-associated virus vector.
Byun J; Heard JM; Huh JE; Park SJ; Jung EA; Jeong JO; Gwon HC; Kim DK
J Mol Cell Cardiol; 2001 Feb; 33(2):295-305. PubMed ID: 11162134
[TBL] [Abstract][Full Text] [Related]
4. Selective Rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines.
Liu X; Voulgaropoulou F; Chen R; Johnson PR; Clark KR
Mol Ther; 2000 Oct; 2(4):394-403. PubMed ID: 11020356
[TBL] [Abstract][Full Text] [Related]
5. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
[TBL] [Abstract][Full Text] [Related]
6. An improved system for packaging recombinant adeno-associated virus vectors capable of in vivo transduction.
Flotte TR; Barraza-Ortiz X; Solow R; Afione SA; Carter BJ; Guggino WB
Gene Ther; 1995 Jan; 2(1):29-37. PubMed ID: 7712331
[TBL] [Abstract][Full Text] [Related]
7. Development and characterization of a cell line for large-scale, serum-free production of recombinant adeno-associated viral vectors.
Farson D; Harding TC; Tao L; Liu J; Powell S; Vimal V; Yendluri S; Koprivnikar K; Ho K; Twitty C; Husak P; Lin A; Snyder RO; Donahue BA
J Gene Med; 2004 Dec; 6(12):1369-81. PubMed ID: 15538729
[TBL] [Abstract][Full Text] [Related]
8. Improved adeno-associated virus vector production with transfection of a single helper adenovirus gene, E4orf6.
Allen JM; Halbert CL; Miller AD
Mol Ther; 2000 Jan; 1(1):88-95. PubMed ID: 10933916
[TBL] [Abstract][Full Text] [Related]
9. Generation of efficient human blood progenitor-targeted recombinant adeno-associated viral vectors (AAV) by applying an AAV random peptide library on primary human hematopoietic progenitor cells.
Sellner L; Stiefelhagen M; Kleinschmidt JA; Laufs S; Wenz F; Fruehauf S; Zeller WJ; Veldwijk MR
Exp Hematol; 2008 Aug; 36(8):957-64. PubMed ID: 18495326
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of adenovirus cytotoxicity, replication, and E2a gene expression by adeno-associated virus.
Jing XJ; Kalman-Maltese V; Cao X; Yang Q; Trempe JP
Virology; 2001 Dec; 291(1):140-51. PubMed ID: 11878883
[TBL] [Abstract][Full Text] [Related]
11. Generation of recombinant adeno-associated virus vectors by a complete adenovirus-mediated approach.
Zhang X; Li CY
Mol Ther; 2001 May; 3(5 Pt 1):787-92. PubMed ID: 11356083
[TBL] [Abstract][Full Text] [Related]
12. Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors.
Recchia A; Perani L; Sartori D; Olgiati C; Mavilio F
Mol Ther; 2004 Oct; 10(4):660-70. PubMed ID: 15451450
[TBL] [Abstract][Full Text] [Related]
13. Adeno-associated virus vectors for gene therapy.
Flotte TR; Carter BJ
Gene Ther; 1995 Aug; 2(6):357-62. PubMed ID: 7584109
[TBL] [Abstract][Full Text] [Related]
14. Recombinant adenovirus expressing adeno-associated virus cap and rep proteins supports production of high-titer recombinant adeno-associated virus.
Zhang HG; Wang YM; Xie JF; Liang X; Hsu HC; Zhang X; Douglas J; Curiel DT; Mountz JD
Gene Ther; 2001 May; 8(9):704-12. PubMed ID: 11406765
[TBL] [Abstract][Full Text] [Related]
15. [Gene transfer using adeno-associated virus (AAV) vectors].
Shimada T
Nihon Rinsho; 1997 Aug; 55(8):2156-9. PubMed ID: 9284438
[TBL] [Abstract][Full Text] [Related]
16. Transfer of the full-length dystrophin-coding sequence into muscle cells by a dual high-capacity hybrid viral vector with site-specific integration ability.
Gonçalves MA; van Nierop GP; Tijssen MR; Lefesvre P; Knaän-Shanzer S; van der Velde I; van Bekkum DW; Valerio D; de Vries AA
J Virol; 2005 Mar; 79(5):3146-62. PubMed ID: 15709034
[TBL] [Abstract][Full Text] [Related]
17. Development and characterization of an antisense-mediated prepackaging cell line for adeno-associated virus vector production.
Okada T; Mizukami H; Urabe M; Nomoto T; Matsushita T; Hanazono Y; Kume A; Tobita K; Ozawa K
Biochem Biophys Res Commun; 2001 Oct; 288(1):62-8. PubMed ID: 11594752
[TBL] [Abstract][Full Text] [Related]
18. Site-specific integration of a transgene mediated by a hybrid adenovirus/adeno-associated virus vector using the Cre/loxP-expression-switching system.
Ueno T; Matsumura H; Tanaka K; Iwasaki T; Ueno M; Fujinaga K; Asada K; Kato I
Biochem Biophys Res Commun; 2000 Jul; 273(2):473-8. PubMed ID: 10873630
[TBL] [Abstract][Full Text] [Related]
19. Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids.
Booth MJ; Mistry A; Li X; Thrasher A; Coffin RS
Gene Ther; 2004 May; 11(10):829-37. PubMed ID: 14985784
[TBL] [Abstract][Full Text] [Related]
20. A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors.
Clark KR; Voulgaropoulou F; Johnson PR
Gene Ther; 1996 Dec; 3(12):1124-32. PubMed ID: 8986439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
